HIGD2A and hepatocellular carcinoma: Additionally, reports have shown that HIGD2A knockdown inhibits the proliferation of HCC cells by interfering with the MAPK/ERK pathway, and persons with lower expression of HIGD2A in LIHC exhibit higher survival rates (73).